These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12522013)

  • 61. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
    Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Navigating Diagnostic and Therapeutic Challenges in Primary Cutaneous Gamma/Delta T-Cell Lymphoma: A Case Study of Fatal Outcomes Within Two Months.
    Shaker N; Blankenship H; Masatkar V; Niu S; Sangueza OP
    Am J Dermatopathol; 2024 Sep; 46(9):593-596. PubMed ID: 39150181
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A skin lesion that catches the eye.
    Louter L; Botden IP; Schop RF
    Neth J Med; 2014 Jun; 72(5):294-5. PubMed ID: 24930467
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cutaneous gamma/delta T-cell lymphoma treated with radiation and denileukin diftitox.
    Vidulich K; Jones D; Duvic M
    Clin Lymphoma Myeloma; 2008 Feb; 8(1):55-8. PubMed ID: 18501089
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased percentage of CD8+CD28- suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease in patients with cutaneous T-cell lymphomas.
    Urbaniak-Kujda D; Kapelko-Słowik K; Wołowiec D; Dybko J; Hałoń A; Jaźwiec B; Maj J; Jankowska-Konsur A; Kuliczkowski K
    Postepy Hig Med Dosw (Online); 2009 Jul; 63():355-9. PubMed ID: 19644152
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.
    Belhadj K; Reyes F; Farcet JP; Tilly H; Bastard C; Angonin R; Deconinck E; Charlotte F; Leblond V; Labouyrie E; Lederlin P; Emile JF; Delmas-Marsalet B; Arnulf B; Zafrani ES; Gaulard P
    Blood; 2003 Dec; 102(13):4261-9. PubMed ID: 12907441
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
    Grange F; Petrella T; Beylot-Barry M; Joly P; D'Incan M; Delaunay M; Machet L; Avril MF; Dalac S; Bernard P; Carlotti A; Esteve E; Vergier B; Dechelotte P; Cassagnau E; Courville P; Saiag P; Laroche L; Bagot M; Wechsler J
    Blood; 2004 May; 103(10):3662-8. PubMed ID: 14726400
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.
    Gaulard P; Bourquelot P; Kanavaros P; Haioun C; Le Couedic JP; Divine M; Goossens M; Zafrani ES; Farcet JP; Reyes F
    Am J Pathol; 1990 Sep; 137(3):617-28. PubMed ID: 1698028
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.
    Wong KF; Chan JK; Matutes E; McCarthy K; Ng CS; Chan CH; Ma SK
    Am J Surg Pathol; 1995 Jun; 19(6):718-26. PubMed ID: 7755158
    [TBL] [Abstract][Full Text] [Related]  

  • 70. T cells with gamma/delta T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-alpha-deficient lpr mice.
    Hughes DP; Hayday A; Craft JE; Owen MJ; Crispe IN
    J Exp Med; 1995 Jul; 182(1):233-41. PubMed ID: 7540652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course.
    Vega F; Luthra R; Medeiros LJ; Dunmire V; Lee SJ; Duvic M; Jones D
    Blood; 2002 Nov; 100(9):3369-73. PubMed ID: 12384439
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
    Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients.
    Joly P; Charlotte F; Leibowitch M; Haioun C; Wechsler J; Dreyfus F; Escande JP; Revuz J; Reyes F; Varet B
    J Clin Oncol; 1991 Nov; 9(11):1994-2001. PubMed ID: 1941058
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidermotropic B-Cell Lymphoma: A Unique Subset of CXCR3-Positive Marginal Zone Lymphoma.
    Magro CM; Momtahen S; Lee BA; Swanson DL; Pavlovic MD
    Am J Dermatopathol; 2016 Feb; 38(2):105-12. PubMed ID: 26275313
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic clinicopathologic factors in cutaneous T-cell lymphoma.
    Martí RM; Estrach T; Reverter JC; Mascaró JM
    Arch Dermatol; 1991 Oct; 127(10):1511-6. PubMed ID: 1929458
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas.
    Dommann SN; Dommann-Scherrer CC; Dours-Zimmermann MT; Zimmermann DR; Kural-Serbes B; Burg G
    Arch Dermatol Res; 1996 Apr; 288(4):163-7. PubMed ID: 8967786
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype.
    de Bruin PC; Beljaards RC; van Heerde P; Van Der Valk P; Noorduyn LA; Van Krieken JH; Kluin-Nelemans JC; Willemze R; Meijer CJ
    Histopathology; 1993 Aug; 23(2):127-35. PubMed ID: 8406384
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients.
    Hoque SR; Child FJ; Whittaker SJ; Ferreira S; Orchard G; Jenner K; Spittle M; Russell-Jones R
    Br J Dermatol; 2003 Mar; 148(3):516-25. PubMed ID: 12653744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.